| Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial RS Kahn, WW Fleischhacker, H Boter, M Davidson, Y Vergouwe, ... The lancet 371 (9618), 1085-1097, 2008 | 1481 | 2008 |
| Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) M Davidson, S Galderisi, M Weiser, N Werbeloff, WW Fleischhacker, ... American Journal of Psychiatry 166 (6), 675-682, 2009 | 451 | 2009 |
| Links among resting-state default-mode network, salience network, and symptomatology in schizophrenia F Orliac, M Naveau, M Joliot, N Delcroix, A Razafimandimby, P Brazo, ... Schizophrenia research 148 (1-3), 74-80, 2013 | 208 | 2013 |
| EPA guidance on assessment of negative symptoms in schizophrenia S Galderisi, A Mucci, S Dollfus, M Nordentoft, P Falkai, S Kaiser, ... European Psychiatry 64 (1), e23, 2021 | 163 | 2021 |
| Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study S Galderisi, M Davidson, RS Kahn, A Mucci, H Boter, MD Gheorghe, ... Schizophrenia research 115 (2-3), 104-114, 2009 | 157 | 2009 |
| Cognitive patterns in subtypes of schizophrenia P Brazo, RM Marie, I Halbecq, K Benali, L Segard, P Delamillieure, ... European Psychiatry 17 (3), 155-162, 2002 | 151 | 2002 |
| Atypical hemispheric specialization for language in right-handed schizophrenia patients S Dollfus, A Razafimandimby, P Delamillieure, P Brazo, M Joliot, ... Biological psychiatry 57 (9), 1020-1028, 2005 | 144 | 2005 |
| Self-evaluation of negative symptoms: a novel tool to assess negative symptoms S Dollfus, C Mach, R Morello Schizophrenia Bulletin 42 (3), 571-578, 2016 | 142 | 2016 |
| Hyperprolinemia is a risk factor for schizoaffective disorder H Jacquet, C Demily, E Houy, B Hecketsweiler, J Bou, G Raux, J Lerond, ... Molecular psychiatry 10 (5), 479-485, 2005 | 125 | 2005 |
| Identifying subtypes of schizophrenia by cluster analyses S Dollfus, B Everitt, JM Ribeyre, F Assouly-Besse, C Sharp, M Petit Schizophrenia bulletin 22 (3), 545-555, 1996 | 120 | 1996 |
| Summer birth and deficit schizophrenia: a pooled analysis from 6 countries E Messias, B Kirkpatrick, E Bromet, D Ross, RW Buchanan, WT Carpenter, ... Archives of general psychiatry 61 (10), 985-989, 2004 | 118 | 2004 |
| A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. M Petit, J Raniwalla, J Tweed, E Leutenegger, S Dollfus, F Kelly Psychopharmacology bulletin 32 (1), 81-87, 1996 | 111 | 1996 |
| EPA guidance on treatment of negative symptoms in schizophrenia S Galderisi, S Kaiser, I Bitter, M Nordentoft, A Mucci, M Sabé, ... European Psychiatry 64 (1), e21, 2021 | 110 | 2021 |
| Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6 month follow-up pilot study A Montagne-Larmurier, O Etard, A Razafimandimby, R Morello, S Dollfus Schizophrenia Research 113 (1), 77-83, 2009 | 110 | 2009 |
| Current developments and challenges in the assessment of negative symptoms TM Lincoln, S Dollfus, J Lyne Schizophrenia research 186, 8-18, 2017 | 109 | 2017 |
| Executive/attentional cognitive functions in schizophrenic patients and their parents: a preliminary study S Dollfus, C Lombardo, K Bénali, I Halbecq, P Abadie, RM Marié, P Brazo Schizophrenia research 53 (1-2), 93-99, 2002 | 107 | 2002 |
| A concordance study of three electrophysiological measures in schizophrenia S Louchart-de la Chapelle, I Nkam, E Houy, A Belmont, JF Ménard, ... American Journal of Psychiatry 162 (3), 466-474, 2005 | 92 | 2005 |
| Proton Magnetic Resonance Spectroscopy (1H MRS) in Schizophrenia: Investigation of the Right and Left Hippocampus, Thalamus, and Prefrontal Cortex P Delamillieure, JM Constans, J Fernandez, P Brazo, K Benali, ... Schizophrenia bulletin 28 (2), 329-339, 2002 | 89 | 2002 |
| P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia S Louchart-de la Chapelle, D Levillain, JF Ménard, A Van der Elst, G Allio, ... Psychiatry research 136 (1), 27-34, 2005 | 86 | 2005 |
| Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms P Brazo, P Delamillieure, R Morello, I Halbecq, RM Marié, S Dollfus Psychiatry Research 133 (1), 45-55, 2005 | 84 | 2005 |
